Member Info for busicat

Thanks for saying, Carrington.

I would've done the same if I hadn't already cut back in January and closed out on Thursday, to grab cash for"bargains"!

But not wanting to miss out on any remaining rise, I popped my last third back in this morning, so fingers crossed...!

This afternoon's TR-1 increase news makes me hope that wasn't a mistake.

Ey up, a sudden run back up looking interesting

I suppose 380 might be worth a try in these turbulent times.

But I'm happy to have had the chance to top up already below the 407.2 at which the Chair was willing to pop in his £893,298 yesterday.

Here we go - today's move up seems to be getting finally underway

Yes, I've been thinking the same.

Something seems to be up!

Thanks Lionel. Heartening to see Professor Newman's optimistic comments concluding this blog:

"Without NICE's healthtech guidance and the coordinated support from NIHR, the Office for Life Sciences and Health Innovation Manchester, this technology might have remained confined to a single hospital. Instead, we now have a clear pathway to national adoption. The prospect that every at-risk baby across the UK could access this life-changing test is genuinely exciting.

Beyond the personal satisfaction, the project has demonstrated real progress on multiple fronts. The test failure rate has dropped from 15% in our initial study to 5% today, making the technology increasingly reliable. International interest is also growing, with several countries now exploring adoption of this UK-developed innovation."

A surge at open on NYSE seems to have give a further boost to today's run back up

He's an old buffer ; )

Thanks Pokerchips. Worth a look if only for this, for me:

"Cindy Gallop CEO

0:03:12

In the Q4 of 2025, WPP was number one in JP Morgan's net new business rankings for the first time since 2020, with a series of excellent client wins across media, creative, and our integrated offer. These include being appointed the U.K. government's lead media agency, Reckitt and Henkel Media in Europe, Kenvue and Haleon Creative globally, TruGreen Media in the U.S., Norwegian Cruise Line Global Media, Suncorp Media, just to name a few. I'm delighted to say we've maintained this strong momentum into 2026, winning Jaguar Land Rover, Global Media, and Integrated Services. In fact, the impact from new business wins in 2026 already exceeds the impact of new business wins for all of 2025 combined, and it's only February."

£100,485 buy at 115.5p by the Chair is just the confirmation I needed for my re-entry point here

Oh, ho - not one but two. Just like busses!

Market seems to like number two as well!

Well it seems an RNS was indeed on the way and the market seems to like it.

Fingers crossed, having. jumped back in today.

Nosing around for clues, I've also just seen this good news at Tiprank just puvblished 20mins ago:

"Oxford Nanopore secured an admission in Australia that MGI’s Cyclone SEQ WT02 infringes four of its patents, with a 2027 trial set to address remaining defences and potential damages.

The company has also sued MGI and BGI entities in the UK for alleged trade secrets misuse and contract breaches, highlighting an aggressive stance on protecting IP that underpins its global sensing platform business."

Well played today, Maverick, but I doubt you'll get a chance to repeat the process at 255, at the rate this is going (and other shares that were hit by the AI panic).

But who knows, after today's likely profit-taking, maybe there'll be another chance

Whoops, just reposting answer to Probo on right thread:

As previously shared a little while back, there's a very detailed presentation to health insiders by the project leader of how the NHS Scotland roll-out is going. It explains the many challenges of implementation which go a long way to explaining to outsiders why uptake has been slower than deserved, but to me conveys genuine enthusiasm and positivity about how this lays the foundations for future equivalent roll-outs.

A quote I liked about the reception by clinicians: "encouraging from the current sites that have gone live, they're actually testing more [than expected] so that that kind of says it all"

Webinar and transcript is here: https://www.youtube.com/watch?v=83-raU3m_1g

Hi Probo

As previously shared a little while back, there's a very detailed presentation to health insiders by the project leader of how the NHS Scotland roll-out is going. It explains the many challenges of implementation which go a long way to explaining to outsiders why uptake has been slower than deserved, but to me conveys genuine enthusiasm and positivity about how this lays the foundations for future equivalent roll-outs.

A quote I liked about the reception by clinicians: "encouraging from the current sites that have gone live, they're actually testing more [than expected] so that that kind of says it all"

Webinar and transcript is here: https://www.youtube.com/watch?v=83-raU3m_1g

Bargain territory here, with results due out 17/3 - led me to check out 2026 UK mortgage market prospects:

AI: "The UK mortgage market in 2026 isprojected to experience a resurgence in activity, driven by falling interest rates and improved affordability, with rates potentially dropping below 3.5% for some products. Following a stabilization in 2025, 2026 is expected to be a "booming market" for products, featuring higher mortgage choice, modest house price growth of 1-5%, and a surge in remortgaging.

Mortgage Market Trends 2026:

Rate Reductions: Following a rocky 2025, mortgage rates are expected to continue falling throughout 2026 as inflation targets are met.

Competition & Choice: Mortgage product availability is at its highest level in 18 years, with lenders fighting for market share.

Volume Increase: Total gross lending is forecast to rise by 4% to £300 billion, with 1.8 million borrowers reaching the end of fixed-rate deals and needing to refinance.

Product Transfers & Remortgaging: External remortgaging is set to rise by 10%, while internal product transfers are predicted to increase by 2%, as homeowners search for better deals.

Interest Rate & Property Outlook:

Bank of England Base Rate: Forecasts suggest the base rate could fall to around 3.25% by the end of 2026, boosting market confidence.

Housing Demand: Lower rates are predicted to increase buyer demand, though affordability challenges will remain, particularly for first-time buyers.

Market Stability: After a period of high rates, 2026 is viewed as a turning point where the market adjusts to a "new normal," enabling more sustainable growth.

Borrower Advice:

Prepare for Refinancing: With 1.8 million fixed-rate deals expiring in 2026, homeowners should review their options early.

Seek Advice: Working with a mortgage broker will be crucial to finding the best deals as the market becomes more competitive."

Nice one: 136.22 average price for £600k buyback after reduction in previous volume of buybacks signals to me not just robotic purchase process but sensible riding of sentiment

Market seems as happy as I am with report published today (and dividend 7% increase to 67.5p (63.0p).!)

Chairman's remarks:

"All business areas performed well producing underlying revenue growth of 7%, and underlying adjusted operating profit growth of 9%. Adjusted earnings per share grew 10% at constant currency to 128.5p (120.1p). Reported earnings per share were 112.6p (103.6p).

During the past few months, we have seen share price volatility across a number of sectors, including software and data services. Against that backdrop, I remain confident in our ability to continue to leverage new technologies, deliver enhanced value to customers and execute our strategy over the long term."